REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/08/2025
Back to search
Official data from USPTO
IMMUNOGENESIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMUNOGENESIS
ST13
US500000088490659Class
42
Filing
88490659
Registration
6218717
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
12/09/2025
Trademark type
Word
Nice classes
42
Filing date
06/26/2019
Registration date
12/08/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/08/2020
Last transaction
12/09/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
2020-05-00
First use in commerce
2020-05-00
Drawing code
4
Owner type
03
Owner location
Houston, TX
Examiner
IN,SUNG HYUN
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Immunogenesis, Inc.
Representatives
Immunogenesis, Inc.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development in the pharmaceutical field; biotechnology research
Publications
History of USPTO decisions and trademark events.
27 publications found
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
08/10/2021
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
08/10/2021
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
12/08/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/03/2020
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
10/24/2020
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
10/23/2020
IUAA
USE AMENDMENT ACCEPTED
10/23/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/22/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/22/2020
ALIE
ASSIGNED TO LIE
10/22/2020
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
09/09/2020
IUAF
USE AMENDMENT FILED
09/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/08/2020
EAAU
TEAS AMENDMENT OF USE RECEIVED
09/08/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/10/2020
GNRT
NON-FINAL ACTION E-MAILED
04/10/2020
CNRT
NON-FINAL ACTION WRITTEN
04/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/20/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/20/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/20/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/21/2019
GNRT
NON-FINAL ACTION E-MAILED
09/21/2019
CNRT
NON-FINAL ACTION WRITTEN
09/21/2019
DOCK
ASSIGNED TO EXAMINER
09/16/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/08/2019
NWAP
NEW APPLICATION ENTERED
06/29/2019
Continuous trademark protection
Get notified about every new filing that threatens IMMUNOGENESIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.